ClinVar Miner

Submissions for variant NM_020975.6(RET):c.1010_1017del (p.Glu337fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002435695 SCV002750792 pathogenic Hereditary cancer-predisposing syndrome 2022-04-28 criteria provided, single submitter clinical testing The c.1010_1017delAGACCTCG pathogenic mutation, located in coding exon 5 of the RET gene, results from a deletion of 8 nucleotides at nucleotide positions 1010 to 1017, causing a translational frameshift with a predicted alternate stop codon (p.E337Gfs*14). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Loss-of-function variants in RET are known to cause Hirschsprung disease; however, such associations with Multiple Endocrine Neoplasia Type-2 (MEN2) have not been observed (Amiel J and Lyonnet S. J Med Genet. 2001 Nov;38(11):729-39; Wagner SM et al. Clinics (Sao Paulo). 2012;67 Suppl 1(Suppl 1):77-84). Based on the supporting evidence, this alteration is pathogenic for Hirschsprung disease; however, the association of this alteration with MEN2 is unlikely.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.